RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.
about
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications.Lipid metabolism disorders and bone dysfunction--interrelated and mutually regulated (review)Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivoBone disease in newly diagnosed lupus nephritis patientsAmelogenesis imperfecta and other biomineralization defects in Fam20a and Fam20c null miceAssociation of serum osteoprotegerin with left ventricular mass in African American adults with hypertension.Elevated IL-37 levels in the plasma of patients with severe coronary artery calcificationElevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional studyOptimizing bone health and minimizing skeletal morbidity in men with prostate cancerOsteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes.Osteoprotegerin as a marker of atherosclerosis: a systematic update.Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone lossTreated Hypertension has No Influence on the Efficacy of Alendronate in the Therapy of Postmenopausal Osteoporosis: A Non-Randomized, Non-Blind, Controlled Prospective Study.Bone mass regulation of leptin and postmenopausal osteoporosis with obesity.Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levelsOsteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.Attenuated monocyte apoptosis, a new mechanism for osteoporosis suggested by a transcriptome-wide expression study of monocytesTranscription factor decoy (TFD) in breast cancer research and treatment.The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathyStatin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor.Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes.Osteogenic regulation of vascular calcification: an early perspective.Effect of Ultra-marathon (308 km) Race on Bone Metabolism and Cartilage Damage Biomarkers.Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcificationOsteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies.Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular functionA Metabolic Study of Huntington's Disease.Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification?Bone metabolism and vascular calcification.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetesAbdominal aortic calcification, BMD, and bone microstructure: a population-based study.Circasemidian rather than circadian variation of circulating osteoprotegerin in clinical healthLarge-scale association study for structural soundness and leg locomotion traits in the pigOsteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor genePotential Markers in Cardiac Hypertrophy?Arterial calcifications.Osteoprotegerin, vascular calcification and atherosclerosis.
P2860
Q27692635-3D90F766-00EA-4156-A98D-F04B7C90CDCCQ28083206-FB81ECFF-E6A8-4366-9F87-4E7FE888F4E9Q28191731-21878E14-7249-488F-A8C0-00F4E4B775E9Q28543032-9A20670F-2230-4F13-81B1-C429154AC967Q28593754-D66D773E-863D-48D0-BC99-B346864461CFQ30477731-888C75AB-102D-42AE-90D3-EB2591D345F5Q33785539-F384F6FD-296F-4AB8-B5CD-A6E960E323DCQ33811250-806D2A2C-EA75-4BEE-A574-482844403149Q34023510-626BAFDC-C13F-40AC-AF43-81D7C60CA896Q34229800-8092D2F6-4296-41DD-AB7C-5A92F5F39F3CQ34234163-2C2C75AC-2D07-4FCE-96C5-4CA2F8948611Q34440102-A2B94F5E-C7F3-4055-90DD-21964DB23601Q34522217-1852F4E1-1A62-4EB1-B617-B494A3CA0FD9Q34536487-3CB18D4B-97FE-4246-914A-F9420106BADEQ34555532-D540A9BD-92CC-4795-8FD0-F7DE056505A3Q34950497-9E2F551E-6E91-4B9A-9DDE-81A4613EC543Q34989869-71059DC5-5239-43C0-97B9-D96D24BB07D0Q35057796-86B82912-F534-4416-93DA-32AE0617200AQ35081110-83E461EC-3E4F-4682-BDD3-83CCAFE972EEQ35123561-5DE1F676-FC30-4CA3-B6E4-55CDED290138Q35125558-427FD9C1-BE0C-4DD6-A4D1-76C133A9189CQ35658848-4C3077B5-90B3-4F03-9338-53055049DC7EQ35742069-B6B532D2-7663-4D0A-A5C3-9F895D068193Q35753562-C2D0996B-F76A-4C07-9BA9-708C42433767Q35843620-5A0D25BF-7FB3-4EFF-8520-CABEE7EB2873Q35928260-4D429445-E61D-401C-8F7E-68B09725351AQ36162995-118913BA-3C1D-4638-941B-A99320E82826Q36295418-E68BDBEA-58C2-4634-A6F5-ADC19A086A1FQ36445216-DF7648C8-81E0-4E6E-942B-1B3CBA0E9ADDQ36661096-0D7CA756-C2DA-46AD-813E-230270B13130Q36777391-31CE063A-21D0-4504-8CE9-ACF0433DE68AQ36860987-ECAB0E64-256C-4B4F-9160-C5513F99A973Q36942172-18A3BEC2-1D68-415A-AFB7-6680ABD76736Q37020896-03EB0C60-925E-4E64-9062-45487403A90EQ37074469-F601D2D9-7A27-444D-9108-A82993804FF3Q37133627-82E909D3-01C0-4006-81ED-415525F12938Q37149062-4D72C6D0-EEDF-4CA0-B8DF-E9B0B8DCFB0EQ37155198-A0E123AC-3799-4D3F-B694-43AEFEBAF295Q37293900-75DE9B2B-69AC-402E-B6A4-B5A78806A6F7Q37310825-F2D03236-7D2C-4A27-8E57-44EAABA64206
P2860
RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
RANK ligand and osteoprotegeri ...... abolism and vascular function.
@ast
RANK ligand and osteoprotegeri ...... abolism and vascular function.
@en
RANK ligand and osteoprotegeri ...... abolism and vascular function.
@nl
type
label
RANK ligand and osteoprotegeri ...... abolism and vascular function.
@ast
RANK ligand and osteoprotegeri ...... abolism and vascular function.
@en
RANK ligand and osteoprotegeri ...... abolism and vascular function.
@nl
prefLabel
RANK ligand and osteoprotegeri ...... abolism and vascular function.
@ast
RANK ligand and osteoprotegeri ...... abolism and vascular function.
@en
RANK ligand and osteoprotegeri ...... abolism and vascular function.
@nl
P1476
RANK ligand and osteoprotegeri ...... abolism and vascular function.
@en
P2093
Lorenz C Hofbauer
Michael Schoppet
P304
P356
10.1161/01.ATV.0000012303.37971.DA
P407
P577
2002-04-01T00:00:00Z